Role and therapeutic potential of Glycodelin A in systemic lupus erythematosus

被引:0
|
作者
Hai-Feng Pan
Rui-Xue Leng
Ning Zhang
Jin-Hui Tao
Dong-Qing Ye
机构
[1] Anhui Medical University,Department of Epidemiology and Biostatistics, School of Public Health
[2] Anhui Provincial Hospital,Department of Rheumatology
来源
Rheumatology International | 2011年 / 31卷
关键词
Glycodelin A; Systemic lupus erythematosus; Therapeutic target;
D O I
暂无
中图分类号
学科分类号
摘要
Glycodelin A (GdA) is a lipocalin with an immunomodulatory role. Low expression of GdA has been implicated in the progression of autoimmune disease. Therefore, strategies targeting GdA may constitute an important target for the design of drugs for autoimmune disease including systemic lupus erythematosus (SLE). This opinion article will focus on current understanding of the role of GdA in the physiological and pathological functions associated with SLE. It is the intention of the article to provide insights that may assist in the development of GdA-based approaches for the treatment of SLE.
引用
收藏
页码:563 / 565
页数:2
相关论文
共 50 条
  • [31] TIM-3 as a new therapeutic target in systemic lupus erythematosus
    Pan, Hai-Feng
    Zhang, Ning
    Li, Wen-Xian
    Tao, Jin-Hui
    Ye, Dong-Qing
    MOLECULAR BIOLOGY REPORTS, 2010, 37 (01) : 395 - 398
  • [32] IL-23: A Promising Therapeutic Target for Systemic Lupus Erythematosus
    Leng, Rui-Xue
    Pan, Hai-Feng
    Chen, Gui-Mei
    Wang, Chao
    Qin, Wei-Zi
    Chen, Li-Li
    Tao, Jin-Hui
    Ye, Dong-Qing
    ARCHIVES OF MEDICAL RESEARCH, 2010, 41 (03) : 221 - 225
  • [33] TIM-3 as a new therapeutic target in systemic lupus erythematosus
    Hai-Feng Pan
    Ning Zhang
    Wen-Xian Li
    Jin-Hui Tao
    Dong-Qing Ye
    Molecular Biology Reports, 2010, 37 : 395 - 398
  • [34] Toll-like Receptors in Systemic Lupus Erythematosus: Potential Targets for Therapeutic Intervention
    Christopher G. Horton
    A. Darise Farris
    Current Allergy and Asthma Reports, 2012, 12 : 1 - 7
  • [35] Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis
    Marks, Stephen D.
    Tullus, Kjell
    ACTA PAEDIATRICA, 2010, 99 (07) : 967 - 974
  • [36] Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity
    Incaprera, M
    Rindi, L
    Bazzichi, A
    Garzelli, C
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1998, 16 (03) : 289 - 294
  • [37] Systemic lupus erythematosus vasculitis: A current therapeutic overview
    Toubi E.
    Kessel A.
    Bamberger E.
    Golan T.D.
    Current Treatment Options in Cardiovascular Medicine, 2004, 6 (2) : 87 - 97
  • [38] Systemic lupus erythematosus: a therapeutic challenge for the XXI century
    Manuel F. Ugarte-Gil
    Graciela S Alarcón
    Clinical Rheumatology, 2014, 33 : 441 - 450
  • [40] Extracellular Vesicles as Therapeutic Agents in Systemic Lupus Erythematosus
    Perez-Hernandez, Javier
    Redon, Josep
    Cortes, Raquel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (04):